Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related Macular Degeneration Patients: 3-Year Outcomes

被引：0
|
作者：
Wijeyakumar, Wijeyanthy [1 ,2 ]
Zhu, Meidong [1 ,2 ]
Chang, Andrew Alexander [1 ,2 ]
机构：
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4965
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Switching to the aflibercept (3 mg) therapy for treatment-resistant wet age-related macular degeneration: 1-year outcomes
    Feng, Chengcheng
    Chu, Wenjuan
    Lin, Ping
    Xu, Haifeng
    Chen, Xiuli
    [J]. MEDICINE, 2024, 103 (16)
  • [32] LONG-TERM OUTCOMES OF SWITCHING TO AFLIBERCEPT FOR TREATMENT RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Spooner, Kimberly
    Hong, Thomas
    Nair, Rashmi
    Chow, Nicholas Chian Chiang
    Broadhead, Geoffrey
    Wijeyakumar, Wijeyanthy
    Chang, Andrew
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [33] Experience With Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    He, Lingmin
    Silva, Ruwan A.
    Ayoub, Noel
    Moshfeghi, Darius M.
    Leng, Theodore
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (05): : 542 - 549
  • [34] Review of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration
    Stewart, Michael W.
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2013, 5 : 81 - 93
  • [35] Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration and Pigment Epithelial Detachment
    Cidad Betegon, Maria del Pino
    Felix, Armada
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [36] PHARMACOKINETIC STUDY OF INTRAVITREAL AFLIBERCEPT IN HUMANS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Do, Diana V.
    Rhoades, William
    Nguyen, Quan Dong
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (04): : 643 - 647
  • [37] Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept
    Hatz, Katja B.
    Cedro, Luca
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [38] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Rachel Hui Fen Lim
    Bhaskar Gupta
    Peter Simcock
    [J]. International Journal of Ophthalmology, 2017, (03) : 423 - 426
  • [39] Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
    Lim, Rachel Hui Fen
    Gupta, Bhaskar
    Simcock, Peter
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (03) : 423 - 426
  • [40] Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration and Pigment Epithelial Detachment
    Felix, Armada
    Cidad, Pino
    Pastora, Natalia
    Manzano, Beatriz
    Rosa, Irene
    Del Barrio, Zurine
    Mediero, Soraya
    Capote, Maria
    DAnna, Oriana
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
12345